B. Metzler seel. Sohn & Co’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.8M	Buy	8,475 +3,223	+61%	+$1.1M	0.03%	314
2025 Q4	$2.09M	Buy	5,252 +1,339	+34%	+$593K	0.02%	390
2025 Q3	$1.78M	Buy	3,913 +680	+21%	+$277K	0.02%	417
2025 Q2	$1.05M	Hold	3,233	–	–	0.01%	531
2025 Q1	$873K	Sell	3,233 -46	-1%	-$11.8K	0.01%	549
2024 Q4	$772K	Hold	3,279	–	–	0.01%	582
2024 Q3	$902K	Sell	3,279 -738	-18%	-$192K	0.01%	566
2024 Q2	$976K	Buy	4,017 +99	+3%	+$15.6K	0.01%	528
2024 Q1	$586K	Buy	3,918 +190	+5%	+$31.7K	0.01%	599
2023 Q4	$714K	Hold	3,728	–	–	0.01%	554
2023 Q3	$660K	Buy	3,728 +37	+1%	+$7.06K	0.01%	541
2023 Q2	$701K	Hold	3,691	–	–	0.01%	537
2023 Q1	$739K	Buy	3,691 +367	+11%	+$77.1K	0.01%	491
2022 Q4	$790K	Buy	3,324 +1,005	+43%	+$214K	0.01%	470
2022 Q3	$464K	Hold	2,319	–	–	0.01%	553
2022 Q2	$338K	Hold	2,319	–	–	0.01%	623
2022 Q1	$379K	Hold	2,319	–	–	0.01%	650
2021 Q4	$397K	Buy	2,319 +374	+19%	+$69.5K	0.01%	603
2021 Q3	$367K	Hold	1,945	–	–	0.01%	608
2021 Q2	$330K	Buy	1,945 +468	+32%	+$68.5K	﹤0.01%	606
2021 Q1	$209K	Buy	+1,477	New	+$222K	﹤0.01%	659